These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 28642237

  • 1. Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization.
    Bai L, Li Z, Li Q, Guan H, Zhao S, Liu R, Wang R, Zhang J, Jia Y, Fan J, Wang N, Reddy JK, Shyy JY, Liu E.
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1470-1481. PubMed ID: 28642237
    [Abstract] [Full Text] [Related]

  • 2. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L, Yang X, Li Q, Zeng P, Liu Y, Liu L, Chen Y, Yu M, Ma C, Li X, Li Y, Zhang R, Zhu Y, Miao QR, Han J, Duan Y.
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [Abstract] [Full Text] [Related]

  • 3. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y, Yao S, Yan H, Hu L, Yu C, Gao F, Xi C, Li H, Ye Y, Wang Y.
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [Abstract] [Full Text] [Related]

  • 4. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
    Zhu L, Giunzioni I, Tavori H, Covarrubias R, Ding L, Zhang Y, Ormseth M, Major AS, Stafford JM, Linton MF, Fazio S.
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
    [Abstract] [Full Text] [Related]

  • 5. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y, Sukhanov S, Shai SY, Danchuk S, Tang R, Snarski P, Li Z, Lobelle-Rich P, Wang M, Wang D, Yu H, Korthuis R, Delafontaine P.
    Circulation; 2016 Jun 07; 133(23):2263-78. PubMed ID: 27154724
    [Abstract] [Full Text] [Related]

  • 6. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M, Feldmann K, Göthert JR, Dick LS, Homann S, Klatt C, Bayer JK, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Köhrer K, Lehr S, Homey B, Pfeffer K, Fischer JW.
    Circ Res; 2015 Apr 10; 116(8):e57-68. PubMed ID: 25740843
    [Abstract] [Full Text] [Related]

  • 7. Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice.
    Pendse AA, Johnson LA, Kim HS, McNair M, Nipp CT, Wilhelm C, Maeda N.
    Arterioscler Thromb Vasc Biol; 2012 Jun 10; 32(6):1436-44. PubMed ID: 22539598
    [Abstract] [Full Text] [Related]

  • 8. S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population.
    Grimm M, Tischner D, Troidl K, Albarrán Juárez J, Sivaraj KK, Ferreirós Bouzas N, Geisslinger G, Binder CJ, Wettschureck N.
    Arterioscler Thromb Vasc Biol; 2016 Jan 10; 36(1):37-48. PubMed ID: 26603156
    [Abstract] [Full Text] [Related]

  • 9. Nifedipine induces peroxisome proliferator-activated receptor-gamma activation in macrophages and suppresses the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Ishii N, Matsumura T, Kinoshita H, Fukuda K, Motoshima H, Senokuchi T, Nakao S, Tsutsumi A, Kim-Mitsuyama S, Kawada T, Takeya M, Miyamura N, Nishikawa T, Araki E.
    Arterioscler Thromb Vasc Biol; 2010 Aug 10; 30(8):1598-605. PubMed ID: 20508203
    [Abstract] [Full Text] [Related]

  • 10. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P, Gandhi C, Prakash P, Dhanesha N, Grumbach IM, Dailey ME, Lentz SR, Chauhan AK.
    Arterioscler Thromb Vasc Biol; 2015 Nov 10; 35(11):2391-400. PubMed ID: 26427793
    [Abstract] [Full Text] [Related]

  • 11. Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice.
    Wei LL, Ma N, Wu KY, Wang JX, Diao TY, Zhao SJ, Bai L, Liu E, Li ZF, Zhou W, Chen D, Li K.
    Arterioscler Thromb Vasc Biol; 2020 Sep 10; 40(9):2070-2083. PubMed ID: 32762445
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ, Zeng DY, Mai XY, Shang JY, Wu QQ, Yuan JN, Yu BX, Zhou P, Zhang FR, Liu YY, Lv XF, Liu J, Ou JS, Qian JS, Zhou JG.
    Arterioscler Thromb Vasc Biol; 2016 Apr 10; 36(4):618-28. PubMed ID: 26916730
    [Abstract] [Full Text] [Related]

  • 13. Map3k8 Modulates Monocyte State and Atherogenesis in ApoE-/- Mice.
    Sanz-Garcia C, Sánchez Á, Contreras-Jurado C, Cales C, Barranquero C, Muñoz M, Merino R, Escudero P, Sanz MJ, Osada J, Aranda A, Alemany S.
    Arterioscler Thromb Vasc Biol; 2017 Feb 10; 37(2):237-246. PubMed ID: 27856455
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function.
    Mehta NU, Grijalva V, Hama S, Wagner A, Navab M, Fogelman AM, Reddy ST.
    Arterioscler Thromb Vasc Biol; 2016 Jun 10; 36(6):1152-63. PubMed ID: 27079878
    [Abstract] [Full Text] [Related]

  • 15. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53.
    Sayin VI, Khan OM, Pehlivanoglu LE, Staffas A, Ibrahim MX, Asplund A, Agren P, Nilton A, Bergström G, Bergo MO, Borén J, Lindahl P.
    Circ Res; 2014 Oct 10; 115(9):781-9. PubMed ID: 25212213
    [Abstract] [Full Text] [Related]

  • 16. Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.
    Krishnamurthy K, Glaser S, Alpini GD, Cardounel AJ, Liu Z, Ilangovan G.
    Cardiovasc Res; 2016 Jul 01; 111(1):74-83. PubMed ID: 27131506
    [Abstract] [Full Text] [Related]

  • 17. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
    Mueller PA, Zhu L, Tavori H, Huynh K, Giunzioni I, Stafford JM, Linton MF, Fazio S.
    Circulation; 2018 Oct 23; 138(17):1850-1863. PubMed ID: 29794082
    [Abstract] [Full Text] [Related]

  • 18. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
    Hueso M, De Ramon L, Navarro E, Ripoll E, Cruzado JM, Grinyo JM, Torras J.
    Atherosclerosis; 2016 Dec 23; 255():80-89. PubMed ID: 27835742
    [Abstract] [Full Text] [Related]

  • 19. HOXA5 induces M2 macrophage polarization to attenuate carotid atherosclerosis by activating MED1.
    Jing Y, Gao B, Han Z, Xin S.
    IUBMB Life; 2021 Sep 23; 73(9):1142-1152. PubMed ID: 34117711
    [Abstract] [Full Text] [Related]

  • 20. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
    Jiang H, Zhang J, Du Y, Jia X, Yang F, Si S, Wang L, Hong B.
    Atherosclerosis; 2015 Dec 23; 243(2):523-32. PubMed ID: 26523989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.